Saverna Therapeutics AG
PrivateLast Round
Seed
Feb 1, 2020
Total Funding Raised
$1.57M
Company Overview
Saverna Therapeutics AG is a biotechnology company that develops an innovative drug discovery platform combining machine learning, fragment-based screening, and nuclear magnetic resonance spectroscopy to identify small molecule drugs targeting non-coding RNA.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saverna Therapeutics AG Comparables
Compare Saverna Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 85% | |
| Ribometrix | 84% | |
| Base4 Biotechnology | 84% | |
Saverna Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2020 | ||||
| Grant | Apr 1, 2019 |
Saverna Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2024
Monthly visitors grew 394% MoM, from 36 to 178.
- Apr 1, 2019
$1.57M grant received
Saverna Therapeutics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Saverna Therapeutics AG's valuation, stock price, and market status.